Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study Comparing Maintenance With Pemetrexed or Gemcitabine to a Surveillance in Elderly Patients (70 Years Old and More) With a Advanced Non Small Cell Lung Cancer Controlled by Induction Chemotherapy.

NCT01850303 is registered in ClinicalTrials.gov with Intergroupe Francophone de Cancerologie Thoracique as lead sponsor.

NCT NCT01850303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study Comparing Maintenance With Pemetrexed or Gemcitabine to a Surveillance in Elderly Patients (70 Years Old and More) With a Advanced Non Small Cell Lung Cancer Controlled by Induction Chemotherapy.
Lead sponsor
Intergroupe Francophone de Cancerologie Thoracique
Phase
Phase 3
Overall status
Completed
Start date
May 16, 2013
Completion date
January 31, 2020
Enrollment
632 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer (squamous or non squamous)